QmedRx Names Scott Karolchyk VP of Formulations
Nationally Accredited Pharmacy Welcomes Past President of the International Academy of Compounding Pharmacists
(firmenpresse) - ORLANDO, FL -- (Marketwired) -- 10/06/14 -- QmedRx, a compounding pharmacy servicing patients in 49 states through in-home delivery, announces today the appointment of Scott Karolchyk as the new Vice President of Formulations. Karolchyk will oversee formulation development, testing methods and clinical applications in his new role. His specialties include drug formulation and stability, high risk sterile admixtures, transdermal technology, as well as ophthalmic and veterinary compounds.
"Scott's wealth of experience in formulations and pharmacology is exactly what we are looking for to continue to ensure quality, safety, and innovation in the treatments we deliver," said QmedRx Chief Operating Officer Blake Powers "His impressive career in the compound pharmacy industry will undoubtedly prove to be an incredible asset for our company."
Mr. Karolchyk recently sold Pharmacy Creations; a compounding and nutritional pharmacy started in 2000, in Randolph, NJ, to Imprimis Pharmaceuticals and is currently an adjunct professor of Pharmaceutics and preceptor for the College of Pharmacy at Rutgers University.
Karolchyk is currently President of the New Jersey Academy of Compounding Pharmacists and past President of the International Academy of Compounding Pharmacists (IACP).
Compounding medications are an integral part of the practice of pharmacy and the demand for these customized medications is increasing every year. Compounded medications are prescriptions written by physicians, veterinarians and other legally authorized prescribers that are customized for an individual patient to meet special needs and requirements by a specially trained pharmacist.
QmedRx, Inc. is a Florida-based specialty pharmacy and healthcare service company that has been serving patients in their homes since 1990 through its PCAB® and ACHC-accredited pharmacy, Home Care Solutions. The pharmacy is currently servicing patients in 49 states across the nation, extending patient convenience for multi-state families and traveling situations. For more information, visit .
Lauren Bowes
Uproar PR for QmedRx
321-236-0102 x228
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.10.2014 - 13:00 Uhr
Sprache: Deutsch
News-ID 341302
Anzahl Zeichen: 0
contact information:
Town:
ORLANDO, FL
Kategorie:
Alternative
Diese Pressemitteilung wurde bisher 242 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"QmedRx Names Scott Karolchyk VP of Formulations"
steht unter der journalistisch-redaktionellen Verantwortung von
QmedRx (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
